X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The acquisition will provide Gilead with Hepcludex™ (bulevirtide), which was conditionally approved by the European Medicines Agency (EMA) for the treatment of chronic HDV infection in adults with compensated liver disease in July 2020.
Lead Product(s): Bulevirtide Acetate
Therapeutic Area: Infections and Infectious Diseases Product Name: Hepcludex
Highest Development Status: ApprovedProduct Type: Peptide
Partner/Sponsor/Collaborator: Gilead Sciences
Deal Size: $1,762.0 million Upfront Cash: $1,400.0 million
Deal Type: Acquisition December 10, 2020
Details:
On July 31st HEPCLUDEX® was granted Conditional Marketing Authorization (CMA) by the European Commission as the first approved treatment in Europe for adult patients with chronic hepatitis delta virus (HDV) infection and compensated liver disease.
Lead Product(s): Bulevirtide Acetate
Therapeutic Area: Infections and Infectious Diseases Product Name: Hepcludex
Highest Development Status: ApprovedProduct Type: Peptide
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable September 17, 2020
Details:
HEPCLUDEX® has been approved as the first treatment option for adult patients with chronic hepatitis delta virus infection and compensated liver disease in Europe.
Lead Product(s): Bulevirtide
Therapeutic Area: Infections and Infectious Diseases Product Name: Hepcludex
Highest Development Status: ApprovedProduct Type: Peptide
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 04, 2020
Details:
The benefit of HEPCLUDEX® is shown by an effective reduction of HDV RNA levels and improvement of liver inflammation.
Lead Product(s): Bulevirtide
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Phase IIIProduct Type: Peptide
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable May 29, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
